News
OMCL
27.13
-1.09%
-0.30
Clover Health Appoints Peter Kuipers As Chief Financial Officer, Effective As Of The Day After The Filing Of The Co's Quarterly Report On Form 10-Q For The Quarter-Ended March 31, 2024
Clover Health Investments, Corp. Appoints Peter Kuipers as Chief Financial Officer. Mr. Kuipers brings over 25 years of technology leadership experience to the CFO role at Clover. He is the former Executive Vice President and CFO at Omnicell, Inc., a healthcare technology company. He will be responsible for overseeing all financial aspects of the Company.
Benzinga · 3d ago
Weekly Report: what happened at OMCL last week (0415-0419)?
Weekly Report · 4d ago
Peek Under The Hood: VIOO Has 18% Upside
NASDAQ · 04/19 11:02
Shareholders in Omnicell (NASDAQ:OMCL) have lost 81%, as stock drops 4.3% this past week
Omnicell, Inc. Shareholders have lost 56% in the last year. The company's share price has declined 81% over the last three years. The stock has lost 4.3% in just the past week. Omnicell has seen a drop in its share price over the past year. Insider buying has been high in the past 12 months for the company.
Simply Wall St · 04/18 10:49
Omnicell (OMCL) Receives a Buy from Craig-Hallum
TipRanks · 04/17 12:55
Omnicell’s Strategic Shift to Recurring Revenue: A Cautious Hold Amidst Transformation Uncertainty
TipRanks · 04/17 09:07
Omnicell Announces XT Amplify, A Multi-Year Innovation Program That Is Intended To Maximize Value For Hospitals, Health Systems, And Post-Acute Care Facilities That Have Invested In Omnicell's XT Automated Dispensing System
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System Omnicell, Inc. Announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities. The solutions are intended to enhance nursing efficiency and reduce medication errors and waste. The first set of solutions will be available in North America.
Benzinga · 04/16 20:14
Weekly Report: what happened at OMCL last week (0408-0412)?
Weekly Report · 04/15 09:19
25 GDP-sensitive Small-Cap stocks with low refinancing risk - BofA
25 GDP-sensitive Small-Cap stocks with low refinancing risk - BofA. Securities published the top 25 small-cap stocks that rank highly on GDP sensitivity and low on interest rates. Bof a analysts recommend investors focus on areas that can benefit from a GDP, commodity price, and manufacturing recovery.
Seeking Alpha · 04/12 17:43
ClearBridge Small Cap Growth Strategy Q2 2024 Portfolio Manager Commentary
Seeking Alpha · 04/09 15:00
Weekly Report: what happened at OMCL last week (0401-0405)?
Weekly Report · 04/08 09:20
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Glaukos (GKOS) and Omnicell (OMCL)
TipRanks · 04/03 09:40
Weekly Report: what happened at OMCL last week (0325-0329)?
Weekly Report · 04/01 09:20
An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued
Omnicell, Inc. (NASDAQ:OMCL) has a fair value estimate of US$41.02. Current share price of US $29.24 suggests Omnicell is potentially 29% undervalued. Analyst price target for OMCL is US$33.29 which is 19% below its intrinsic value. We use a discounted cash flow model to estimate the value of the company. The model takes the expected future cash flows and discounts them to their present value.
Simply Wall St · 03/28 10:11
Weekly Report: what happened at OMCL last week (0318-0322)?
Weekly Report · 03/25 09:20
Weekly Report: what happened at OMCL last week (0311-0315)?
Weekly Report · 03/18 09:20
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Omnicell will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on March 20, 2024. The company is a leader in transforming the pharmacy care delivery model. Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes-centric innovation.
Barchart · 03/11 16:11
Weekly Report: what happened at OMCL last week (0304-0308)?
Weekly Report · 03/11 09:20
Weekly Report: what happened at OMCL last week (0226-0301)?
Weekly Report · 03/04 09:20
Here's Why You Should Retain Omnicell (OMCL) Stock Now
NASDAQ · 03/01 13:43
More
Webull provides a variety of real-time OMCL stock news. You can receive the latest news about Omnicell Com through multiple platforms. This information may help you make smarter investment decisions.
About OMCL
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.